NDN and neoplasm: The injection of NDN (isolated from LLC-GCSF tumor-bearing mice) resulted in a significant reduction in LKRM tumor growth by means of growth ratio over three consecutive days (p < 0.001, Figure 4A Left panel), as assessed at day 3 (p < 0.05, Figure 4A Right panel) and based on growth rate per day (p < 0.05, Figure 4B).